Modeling hypertrophic IP3 transients in the cardiac myocyte.
Cardiac hypertrophy is a known risk factor for heart disease, and at the cellular level is caused by a complex interaction of signal transduction pathways. The IP3-calcineurin pathway plays an important role in stimulating the transcription factor NFAT which binds to DNA cooperatively with other hypertrophic transcription factors. Using available kinetic data, we construct a mathematical model of the IP3 signal production system after stimulation by a hypertrophic alpha-adrenergic agonist (endothelin-1) in the mouse atrial cardiac myocyte. We use a global sensitivity analysis to identify key controlling parameters with respect to the resultant IP3 transient, including the phosphorylation of cell-membrane receptors, the ligand strength and binding kinetics to precoupled (with G(alpha)GDP) receptor, and the kinetics associated with precoupling the receptors. We show that the kinetics associated with the receptor system contribute to the behavior of the system to a great extent, with precoupled receptors driving the response to extracellular ligand. Finally, by reparameterizing for a second hypertrophic alpha-adrenergic agonist, angiotensin-II, we show that differences in key receptor kinetic and membrane density parameters are sufficient to explain different observed IP3 transients in essentially the same pathway.
Cooling
Michael
M
Auckland Bioengineering Institute, Department of Engineering Science, University of Auckland, New Zealand. m.cooling@auckland.ac.nz
Hunter
Peter
P
Crampin
Edmund J
EJ
D000316:Adrenergic alpha-Agonists / Q000378:metabolism; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D002462:Cell Membrane / Q000378:metabolism; D019332:Endothelin-1 / Q000378:metabolism; D005289:Ferrets; D015544:Inositol 1,4,5-Trisphosphate / Q000737:chemistry*; D008954:Models, Biological; D008962:Models, Theoretical; D032383:Myocytes, Cardiac / Q000378:metabolism*; D054799:Phospholipase C beta / Q000378:metabolism; D010766:Phosphorylation; D051381:Rats; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism; D015398:Signal Transduction
D000316:Adrenergic alpha-Agonists; D019332:Endothelin-1; D043562:Receptors, G-Protein-Coupled; D000804:Angiotensin II; D015544:Inositol 1,4,5-Trisphosphate; D054799:Phospholipase C beta
J Biol Chem. 2000 Jun 9;275(23):17596-604
10747877
Am J Physiol Cell Physiol. 2007 Jan;292(1):C82-97
16870827
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):2947-9
11248009
J Biol Chem. 2001 Apr 20;276(16):13096-103
11150299
Circ Res. 2001 Jun 22;88(12):1239-46
11420299
Cell. 2002 Apr;109 Suppl:S67-79
11983154
J Physiol. 2002 May 15;541(Pt 1):1-8
12015416
Circ Res. 2002 May 31;90(10):1055-63
12039794
EMBO J. 2003 Jan 2;22(1):131-9
12505991
Bioinformatics. 2003 Feb 12;19(3):408-15
12584128
J Cell Biol. 2003 May 26;161(4):779-91
12771127
Prog Cell Cycle Res. 2003;5:219-24
14593716
Chin Med J (Engl). 2004 Jan;117(1):88-93
14733781
Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H1124-32
14630640
Exp Physiol. 2004 Jan;89(1):1-26
15109205
Prog Biophys Mol Biol. 2004 Jun-Jul;85(2-3):433-50
15142756
Biochem Biophys Res Commun. 2004 Oct 1;322(4):1178-91
15336966
Biophys J. 2004 Sep;87(3):1406-16
15345523
Nature. 1991 Apr 11;350(6318):516-8
1707501
Circ Res. 1991 Sep;69(3):800-9
1651818
J Pharmacol Exp Ther. 1992 Sep;262(3):1189-94
1326626
Circ Res. 1993 Sep;73(3):424-38
8348687
Cell. 1993 Dec 3;75(5):977-84
8252633
Circ Res. 1996 Apr;78(4):724-36
8635230
Biochem Pharmacol. 1997 Feb 21;53(4):519-30
9105403
J Biol Chem. 1997 Jul 11;272(28):17734-43
9211925
Biochemistry. 1997 Oct 28;36(43):13325-32
9341224
J Biol Chem. 1998 Feb 27;273(9):5037-46
9478953
Gen Pharmacol. 1998 Mar;30(3):367-72
9510088
Circulation. 1998 Mar 10;97(9):892-9
9521338
Cell. 1998 Apr 17;93(2):215-28
9568714
Braz J Med Biol Res. 2002 Sep;35(9):1001-15
12219172
Life Sci. 1998;62(17-18):1561-5
9585136
Science. 1999 Jan 15;283(5400):381-7
9888852
Cell. 1999 Mar 5;96(5):611-4
10089876
Circ Res. 1999 Apr 2;84(6):633-46
10189351
Am J Physiol. 1999 Apr;276(4 Pt 2):H1197-206
10199843
J Mol Cell Cardiol. 1999 May;31(5):949-70
10336836
Proc Soc Exp Biol Med. 2000 Jan;223(1):53-8
10632961
Z Kardiol. 2000 Jan;89(1):1-6
10663910
J Clin Invest. 2000 May;105(10):1395-406
10811847
J Biol Chem. 2005 Apr 22;280(16):15912-20
15710625
J Biol Chem. 2006 Jan 6;281(1):608-16
16249182
Biophys J. 2006 May 1;90(9):3074-90
16473911
Nat Rev Mol Cell Biol. 2006 Aug;7(8):589-600
16936699
Biotechnol Bioeng. 2000 Oct 20;70(2):225-38
10972934